Navigation Links
Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note Upcoming Conference in New Jersey Pelvic Mesh Implant Lawsuits

New York, New York (PRWEB) April 27, 2013

The transvaginal mesh lawyers at Bernstein Liebhard LLP note that the next Case Management Conference in the New Jersey pelvic mesh litigation has been scheduled for May 16, 2013. Court records indicate that just over 3,100 mesh implant lawsuits involving products manufactured by C.R. Bard Inc., and Johnson & Johnson’s Ethicon Inc. unit have been filed in two consolidated litigations underway in Atlantic County Superior Court. Bernstein Liebhard LLP partner, Jeffrey Grand is serving as Co-Liaison Counsel in both of these pelvic mesh litigations. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)

“We look forward to this next conference, and are pleased to see these litigations moving forward. We continue to hear from women who have allegedly suffered painful transvaginal mesh side effects related to products marketed by both of these companies,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing hundreds of women in mesh implant lawsuits, and continues to offer free legal evaluations to victims of mesh erosion, pain, scarring, infection and other serious injuries, and other alleged transvaginal mesh side effects.

Transvaginal Mesh Lawsuits

Thousands of women filed mesh implant lawsuits against C.R. Bard, Ethicon and other manufacturers in the wake of the U.S. Food & Drug Administration’s (FDA) 2011 Public Safety Alert, in which the agency revealed that there had been a five-fold increase in reports of serious transvaginal mesh side effects, including mesh erosion through vaginal tissue, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. The FDA also modified its previous position on the frequency of such complications, stating in the alert that injuries associated with pelvic organ prolapse repair were not rare. The following January, the agency ordered the manufacturers of mesh implant devices used in transvaginal prolapse repair to conduct post-market safety studies as part of its review. *

The nation’s first trial involving an Ethicon mesh product concluded in New Jersey state court in March, with the jury awarding more than $11 million in compensatory and punitive damages to the Plaintiff. Bernstein Liebhard partner, Jeffrey S. Grand, was a member of the trial team. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))

In addition to the mesh implant lawsuits pending in the New Jersey litigations, thousands of additional claims have been filed in consolidated proceedings now underway in U.S. District Court, Southern District of West Virginia, including: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2327”). Mr. Grand is also serving on the Plaintiffs’ Steering Committee in these four proceedings.

Alleged victims of transvaginal mesh side effects may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding mesh implant lawsuits can be found at Bernstein Liebhard's website. To learn more, please contact a transvaginal mesh lawyer today by calling 1-877-779-1414.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
2. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
3. US Drug Watchdog Now Fears the Numbers of Transvaginal Mesh Product Failure Victims Will Grow and They Offer Victims the Names of the Best Lawyers-Who Will All Be Women
4. US Drug Watchdog Now Urges Transvaginal Mesh, Tape Or Sling Failure Victims To Call Them For The Names Of The Best Possible Attorneys-Who Are All Also Women-Get Help Now
5. US Drug Watchdog Now Offers All Victims Of A Transvaginal Mesh, Sling, or Tape Failure The Names And Contacts Of The Best Possible National Caliber Lawyers Who Are Women
6. US Drug Watchdog Expands Their Transvaginal Mesh Initiative Because Of The Potential Number Of Victims & They are Offering the Names of the Best Women Attorneys To Help
7. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
8. US Drug Watchdog Now Urges All Victims of a Transvaginal Sling, Tape, or Mesh Failure to Call Them for the Names of National Caliber Women Attorneys-Get Help Now
9. Wright & Schulte LLC Files Transvaginal Mesh Lawsuit on Behalf of Woman Allegedly Injured by Align Urethral Support System
10. US Drug Watchdog Now Offers Women Who Are Victims Of A Transvaginal Mesh, Sling, or Tape Medical Product Failure the Names of The Best Possible Lawyers-Who are All Women
11. US Drug Watchdog Is Expanding Their Effort To Ensure Victims Transvaginal Sling,Tape,Or Mesh Failure Get The Names And Contacts of Top Caliber Attorneys-Who Are All Women
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: